Rocket Lab Corporation (NASDAQ:RKLB) experienced a significant decline of approximately 5.4% in late trading on Monday, with shares settling at $76.65. This drop places the stock just 11.9% above a critical price floor that could materially affect the consideration received by Iridium Communications Inc. (NASDAQ:IRDM) shareholders in the planned $8 billion takeover. Iridium shares also fell, declining 2.9% to $48.62.
The central issue revolves around the merger's 'collar' mechanism, a contractual band designed to limit the adjustment of the share exchange ratio. Within a range of $67.50 to $112.50, Iridium holders are entitled to $27 in cash plus a variable number of Rocket Lab shares intended to keep the stock portion near $27. However, if Rocket Lab's stock price falls to or below $67.50, the exchange ratio becomes fixed at 0.4000 Rocket Lab shares per Iridium share, meaning any further decline in Rocket Lab's stock would directly reduce the total payout to Iridium investors. The contract relies on a 10-day volume-weighted average price (VWAP) ending two full trading days before the closing date, not Monday's spot price.
At its current price of $48.62, Iridium offers a gross spread of approximately 11.1% to the deal's headline value of $54 per share. This is not a straightforward fixed-cash arbitrage; half of the notional payment is in Rocket Lab stock. Iridium brings to the table 66 low-Earth-orbit satellites, 2.5 million subscribers, and $871.7 million in 2025 revenue, making the deal a complex mix of cash and equity.
Monday's broader market selling pressure contributed to the decline, though Rocket Lab's slide carries a direct consequence for the merger arithmetic. Space Exploration Technologies Corp. (NASDAQ:SPCX) fell about 4%, while the Invesco QQQ Trust (NASDAQ:QQQ), a key benchmark for large-cap growth stocks, declined 1.9%. This broader weakness underscores the market's risk-off sentiment, which is particularly impactful for high-growth names like Rocket Lab.
Using the merger formula, a hypothetical reference price equal to Monday's Rocket Lab quote of $76.65 would produce approximately 0.3523 Rocket Lab shares per Iridium share, keeping the total consideration near $54. The asymmetry in the payout only becomes apparent outside the collar band. If the reference price falls to $60, the fixed ratio of 0.4000 would yield an implied total consideration of just $51 per Iridium share, a significant reduction from the headline $54.
Iridium reported $495 million in operational EBITDA for 2025, representing a 57% margin. Operational EBITDA is the company's adjusted measure of earnings before interest, tax, depreciation, and amortization. The $8 billion enterprise value equates to roughly 9.2 times revenue and 16.2 times operational EBITDA—a sizable multiple, but one attached to recurring satellite-service income rather than volatile launch revenue alone.
Micah Walter Range, president of space consultancy Caelus Partners, emphasized to Reuters that Iridium's customer base and distribution network 'may prove even more valuable than the hardware, spectrum rights and other assets it gains.' Rocket Lab founder Peter Beck described Iridium as 'a very profitable business … a brand new constellation' with valuable spectrum assets.
This acquisition would significantly alter Rocket Lab's financial profile. The company reported first-quarter revenue of $200.3 million and a net loss of $45 million, while holding approximately $1.48 billion in cash and marketable securities as of March 31. It forecast a second-quarter adjusted EBITDA loss of $20 million to $26 million. Funding and timeline remain key factors in the spread. Rocket Lab secured a $3.6 billion, 364-day senior secured bridge facility from Deutsche Bank and Wells Fargo, which is temporary financing typically replaced with longer-term capital. The deal also requires Iridium shareholder approval, U.S. antitrust and Federal Communications Commission clearance, and foreign satellite and investment approvals, with a June 28, 2027 end date that can be extended to December 28, 2027.
Analyst enthusiasm persists despite the near-term risks. Cantor Fitzgerald reiterated an Overweight rating and $96 price target on Monday, while Morgan Stanley analysts led by Kristine Liwag maintained a $105 base target and raised their bull-case estimate to $293 from $185. The Morgan Stanley team argued that 'the greatest value creation in the space economy comes not from launch alone.'
For now, the collar leaves investors with a simpler near-term arithmetic. Each $1 decline in the eventual reference price below $67.50 reduces the Iridium payout by 40 cents, while each $1 rise above $112.50 adds 24 cents. Between these points, the value remains near $54. The $67.50 level is the cleaner risk marker—not the $293 bull case.
